Advertisement
Loading...

Glaukos Corporation

GKOS•NYSE
Healthcare
Medical - Devices
$144.01
$1.86(1.31%)
U.S. Market opens in 37h 54m

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.5B
P/E Ratio-43.89
EPS (TTM)$-3.29
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$142.19
3 Months$66.94
1 Year Target$135.66

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $135.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -43.89 and a market capitalization of 8.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.30%
5-Day Change
6.57%
1-Month Change
19.008%
3-Month Change
31.54%
6-Month Change
59.95%
Year-to-Date (YTD) Change
27.54%
1-Year Change
57.17%
3-Year Change
140.36%
5-Year Change
95.25%
All-Time (Max) Change
361.24%

Contact Information

https://www.glaukos.com
949 367 9600
229 Avenida Fabricante, Aliso Viejo, CA, 92672

Company Facts

995 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions